| Literature DB >> 27269480 |
Valentina Zanfagnin1, Annamaria Ferrero2, Nicoletta Biglia2, Giovanni Aletti3, Sarah E Gill1, Peter B Makdisi1, Francesco Multinu1, Andrea Mariani1.
Abstract
INTRODUCTION: Endometrial cancer is a common gynecologic malignancy in the United States, and the recurrence rate depends on the disease stage at diagnosis. Recurrence can affect several areas and follow different patterns. AREAS COVERED: The role of surgery at the time of recurrence is not clearly defined. In this review, we fully describe the current evidence available. In particular, we describe how surgical treatment might be recommended for 1) vaginal or pelvic recurrences; 2) retroperitoneal or localized intra-abdominal recurrence, when a maximal cytoreductive effort is more likely to be successful; or 3) isolated distant recurrences when microscopically tumor-free margins can be achieved. Expert commentary: Cases should be evaluated individually, considering factors such as comorbidities, risks of intervention, and impact of treatment on quality of life.Entities:
Keywords: Endometrial neoplasm; intraoperative radiation therapy; metastases; quality of life; secondary cytoreductive surgery
Mesh:
Year: 2016 PMID: 27269480 DOI: 10.1080/14737140.2016.1190650
Source DB: PubMed Journal: Expert Rev Anticancer Ther ISSN: 1473-7140 Impact factor: 4.512